Gustavo Godoy, CEOThe company launched Guia da Farmácia in 1994, which became a leading communication channel for Brazil’s pharmaceutical sector and a trusted source of medicine information. The publication regularly updates data on more than 18,000 marketed medicines and serves as the official medicine and pricing list for over 170 pharmaceutical companies.
Over time, Contento expanded beyond publishing, beginning in 2005 with digital communication, training, industry events, and technology. At the core of this evolution is a commitment to helping healthcare and pharmaceutical organizations communicate complex information clearly and responsibly while maintaining scientific accuracy and regulatory compliance.
“For us, effective healthcare communication is not limited to disseminating information. It is about building trust, understanding, and meaningful connections,” says Gustavo Godoy, CEO.
Turning that principle into practice begins with understanding the communication objective, the audience, and the broader healthcare context. These considerations shape the strategy and determine which combination of formats and channels can best reach the intended audience. Once the strategy is defined, the content team works closely with medical, legal, and regulatory specialists. Evidence-based sources substantiate the scientific content, while review processes ensure alignment with Anvisa requirements. This expertise enables accessible communication that meets compliance requirements for medicines, brands, and treatment-related information.
Beyond content production, the company has developed digital platforms, including Guia da Farmácia Digital and Farma Minuto, to support pharmacy professionals in their day-to-day work. Together, the platforms have more than 20,000 subscribers and use AI-enabled tools to assist with customer service, regulatory matters, identifying potential drug interactions, pharmaceutical interchangeability, and service protocols for pharmaceutical clinics.
-
For us, effective healthcare communication is not limited to disseminating information. It is about building trust, understanding, and meaningful connections.
Beyond content production, the company has developed digital platforms, including Guia da Farmácia Digital and Farma Minuto, to support pharmacy professionals in their day-to-day work. Together, the platforms have more than 20,000 subscribers and use AI-enabled tools to assist with customer service, regulatory matters, identifying potential drug interactions, pharmaceutical interchangeability, and service protocols for pharmaceutical clinics.
Education is another extension of Contento’s healthcare expertise. It has developed pharmacy retail training programs for organizations including Libbs, Sandoz, Bayer, Merck, and EMS. For EMS, the company produced 60 video lessons featuring physicians and pharmacists across 10 specialties, covering diseases, comorbidities, treatments, and relevant therapeutic molecules. The initiative expanded the client’s digital presence and strengthened its institutional positioning in the market.
Through partnerships with institutions including FGV, ESPM, FIA/USP, and São Camilo University, Contento enhances the credibility of its educational content. Across major pharmaceutical events in Brazil, the company curates content and develops experiences focused on technologies and trends shaping pharmacy retail. At Abradilan Conexão Farma, it created the Pharmacy of the Future, a space of more than 200 square meters exploring emerging technologies and the evolving pharmacy retail experience.
Contento serves as the official interview studio for Abrafarma Future Trends, an event that brings together Brazil’s largest pharmacy chains. The company also works with more than 60 healthcare companies on content, advertising, and marketing initiatives. Its pharmacy-chain clients collectively account for at least 70 percent of the country’s pharmaceutical retail revenue.
As healthcare and pharmaceutical communications have shifted from product-centric to patient-centric, evidencebased, and digitally driven approaches, Contento has expanded its capabilities across SEO, GEO, social media, and paid media while preserving its scientific and regulatory rigor. Instead of relying on isolated campaigns, the company develops integrated content journeys designed to build trust, strengthen brand positioning, and measure both immediate results and longer-term effects.
Recognized as the Top Healthcare Content Marketing Agency in Latin America 2026, Contento continues to navigate an increasingly digital, regulated, and audience-specific healthcare environment. Its three decades in the pharmaceutical communications market provide a strong foundation for balancing scientific rigor, regulatory responsibility, and the evolving needs of healthcare audiences.
Making Complex Healthcare Content Clear and Compliant
Healthcare content can be medically accurate and still create exposure if phrasing crosses advertising rules. It can also satisfy compliance review yet lose the audience in technical language. Agency selection becomes unusually demanding under that tension. Executives are buying more than content production. The purchase also covers a process that preserves scientific meaning for each audience’s knowledge level and decision context, then fits the result to the way that audience actually consumes information.
Regulatory discipline belongs inside content development rather than at the end of it. Pharmaceutical communications may involve branded claims or treatment information, each subject to different restrictions. An agency should understand where creative latitude ends, how evidence must be handled, when specialist review is required and who owns final approval. The stronger model reduces late rewrites because writers and reviewers work from the same boundaries early in the process. Review governance deserves scrutiny too. Clear handoffs and documented approval paths matter when content moves repeatedly between creative teams and healthcare specialists.
Audience design presents a different test. One healthcare organization may communicate with patients and prescribers while also addressing pharmacy professionals and institutional stakeholders. Reusing the same message across those groups can flatten important distinctions in language and depth, even when the underlying science is unchanged. Content should be reshaped without weakening that science. Channel selection matters for the same reason. SEO, social media, paid media and customized publications serve different discovery patterns, and their use should follow the communication objective rather than a fixed agency package.
Measurement becomes harder once healthcare marketing extends beyond immediate clicks. A technically useful article or educational series may influence consideration well before it produces a measurable response. Isolated campaign metrics rarely capture that path. Buyers need a partner that links short-term indicators to a longer content journey, then adjusts distribution and subject emphasis using performance evidence. The analysis should reveal which material is earning attention and where the communication sequence is losing relevance. It should also show whether priority audiences are progressing over time.
Procurement teams should test how much healthcare knowledge sits inside the working team. General marketing expertise has limits when every brief requires repeated translation of regulatory context and scientific terminology. Experienced healthcare writers can shorten briefing cycles and make reviews more productive, especially when the agency already understands the conventions of pharmaceutical communication in the market it serves. Sector depth also affects speed after feedback because fewer revisions are spent correcting basic assumptions about the field.
Contento Comunicacao merits consideration as the premier choice for healthcare organizations that need content marketing built around regulatory discipline and audience-specific communication. Its experience is concentrated in healthcare and pharmaceuticals, including content that must account for Brazilian advertising requirements and Anvisa rules. Its planning model begins with audience needs and regulatory limits, then connects content to SEO, GEO, social media and paid distribution when the brief requires it. The agency also works through medical and regulatory review while adapting scientific material for articles, videos, interviews and digital publications. For buyers, the practical case for shortlisting Contento rests on keeping compliance, content depth, channel fit and measurable progression within one engagement.
...Read more
